Gilead Sciences

Paul Carter has been named senior vice president, international commercial operations, Gilead Sciences, Inc. Mr. Carter is responsible for the company’s commercial organization in all territories outside North America, reporting to Kevin Young, Gilead’s executive vice president, commercial operations. Mr. Carter will also join the company’s executive committee.

Mr. Carter joined Gilead in April 2006 to lead the company’s European commercial organization. In October 2006 his role was expanded to encompass all commercial markets outside of North America. Prior to joining the company, Mr. Carter spent 14 years in positions of increasing responsibility at GlaxoSmithKline, including serving as general manager in Europe and regional head of international business in Asia. Previously, he worked for Arthur Andersen’s London-based practice.

“Gilead’s International Operations have grown significantly under Paul’s leadership, with international sales now accounting for more than 40 percent of Gilead’s product revenues,” said Mr. Young. “Paul’s experience and in-depth knowledge of international markets will be instrumental as our portfolio of commercial products continues to grow and as we expand our geographic reach.”